Evidence map›Paper›PMID 32790646›Full record

ArticleThe Journal of clinical investigation2020

Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.

Hélène Louis-Dit-Picard, Ilektra Kouranti, Chloé Rafael, Irmine Loisel-Ferreira, Maria Chavez-Canales, Waed Abdel-Khalek, Eduardo R Argaiz, Stéphanie Baron, Sarah Vacle, Tiffany Migeon and 19 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The evolving concepts of KS-WNK1 effect on NCC activity.American journal of physiology. Renal physiology · 2025
    Review
  5. Review
  6. Familial Hyperkalemic Hypertension.Comprehensive Physiology · 2024
    Review
  7. Article
  8. Deletion of KS-WNK1 promotes NCC activation by increasing WNK1/4 abundance.American journal of physiology. Renal physiology · 2024
    Article
  9. Review
  10. Review
  11. Article
  12. KS-WNK1 is required for the renal response to extreme changes in potassium intake.American journal of physiology. Renal physiology · 2024
    Article
  13. Article
  14. Article
  15. Thirty years of the NaCl cotransporter: from cloning to physiology and structure.American journal of physiology. Renal physiology · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Control of sodium and potassium homeostasis by renal distal convoluted tubules.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 12 institutions in 6 countries.

Hélène Louis-Dit-PicardUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Ilektra KourantiUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Chloé RafaelUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Irmine Loisel-FerreiraUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Maria Chavez-CanalesUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Waed Abdel-KhalekUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Eduardo R ArgaizMolecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.
Stéphanie BaronUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Sarah VacleDepartment of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.
Tiffany MigeonINSERM UMR_S1155, Tenon Hospital, Paris, France.
Richard ColemanDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Marcio Do CruzeiroNSERM U1016, Institut Cochin, Paris, France.
Marguerite HureauxUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Nirubiah ThurairajasingamAP-HP, Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France.
Stéphane DecramerService de Néphrologie Pédiatrique, Hôpital des Enfants, Toulouse, France.
Xavier GirerdAP-HP, Institute of Cardiometabolism and Nutrition (ICAN), Unité de Prévention Cardiovasculaire, Hôpital de La Pitié-Salpêtrière, Paris, France.
Kevin O'ShaugnessyDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Paolo MulateroDivision of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, Italy.
Gwenaëlle RousseyNéphrologie Pédiatrique-Clinique Médicale Pédiatrique, Hôpital Mère Enfant, CHU de Nantes, Nantes, France.
Ivan TackService des Explorations Fonctionnelles Physiologiques, CHU de Toulouse et INSERM U1048-I2MC, Toulouse, France.
Robert UnwinUCL Department of Renal Medicine, University College London, Royal Free Campus and Hospital, London, United Kingdom.
Rosa Vargas-PoussouAP-HP, Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France.
Olivier StaubDepartment of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.
Richard GrimmDepartments of Medicine, Nephrology, and Physiology, Johns Hopkins University Medical School, Baltimore, Maryland, USA.
Paul A WellingDepartments of Medicine, Nephrology, and Physiology, Johns Hopkins University Medical School, Baltimore, Maryland, USA.
Gerardo GambaMolecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.
Eric ClauserUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Juliette HadchouelUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Xavier JeunemaitreUniversité de Paris, INSERM, PARCC, F-75006, Paris, France.
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXJohns Hopkins University · USUniversity of Lausanne · CHHôpital des Enfants · FRHôpital Mère-Enfant · FRInstitut Cochin · FRThe Royal Free Hospital · GBUniversity of Cambridge · GBUniversity of Maryland, Baltimore · USUniversity of Turin · IT

Funding

WNK-SPAK signaling in the Distal NephronR01DK093501 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire, Paul A Welling · 2012 to 2026
$12.1M
Molecular of ROMK Channel FunctionR01DK054231 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI Paul A Welling · 1998 to 2026
$7.7M
OXGR1 in Renal Intercalated Cells, Salt Transport and Diuretic EfficacyR01DK110375 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire, SUSAN MARIE WALL · 2017 to 2026
$6.7M
Molecular Mechanism of ROMK Channel FunctionR56DK054231 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WELLING, PAUL A · 2022 to 2022
$100k
NIDDK NIH HHS R01 DK054231NIDDK NIH HHS R01 DK093501NIDDK NIH HHS R01 DK110375NIDDK NIH HHS R56 DK054231
6 · The paper itself

Abstract

Gain-of-function mutations in with no lysine (K) 1 (WNK1) and WNK4 genes are responsible for familial hyperkalemic hypertension (FHHt), a rare, inherited disorder characterized by arterial hypertension and hyperkalemia with metabolic acidosis. More recently, FHHt-causing mutations in the Kelch-like 3-Cullin 3 (KLHL3-CUL3) E3 ubiquitin ligase complex have shed light on the importance of WNK's cellular degradation on renal ion transport. Using full exome sequencing for a 4-generation family and then targeted sequencing in other suspected cases, we have identified new missense variants in the WNK1 gene clustering in the short conserved acidic motif known to interact with the KLHL3-CUL3 ubiquitin complex. Affected subjects had an early onset of a hyperkalemic hyperchloremic phenotype, but normal blood pressure values"Functional experiments in Xenopus laevis oocytes and HEK293T cells demonstrated that these mutations strongly decrease the ubiquitination of the kidney-specific isoform KS-WNK1 by the KLHL3-CUL3 complex rather than the long ubiquitous catalytically active L-WNK1 isoform. A corresponding CRISPR/Cas9 engineered mouse model recapitulated both the clinical and biological phenotypes. Renal investigations showed increased activation of the Ste20 proline alanine-rich kinase-Na+-Cl- cotransporter (SPAK-NCC) phosphorylation cascade, associated with impaired ROMK apical expression in the distal part of the renal tubule. Together, these new WNK1 genetic variants highlight the importance of the KS-WNK1 isoform abundance on potassium homeostasis.

Indexed as

MutationAcidosisAdaptor Proteins, Signal TransducingAmino Acid MotifsAnimalsCullin ProteinsHEK293 CellsHumansKidney Tubules, DistalMiceMice, Mutant StrainsMicrofilament ProteinsProtein Serine-Threonine KinasesPseudohypoaldosteronismWNK Lysine-Deficient Protein Kinase 1Xenopus laevisAdaptor Proteins, Signal TransducingCUL3 protein, humanCul3 protein, mouseCullin ProteinsKLHL3 protein, humanKLHL3 protein, mouseMicrofilament ProteinsProtein Serine-Threonine KinasesSTK39 protein, humanStk39 protein, mouseWNK1 protein, humanWnk1 protein, mouseWNK Lysine-Deficient Protein Kinase 1Epithelial transport of ions and waterGenetic diseasesGeneticsNephrologyProtein kinases

Identifiers

PMID32790646
PMCPMC7685730
OpenAlexW3049147080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.